These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36089168)

  • 41. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
    Hopes L; Grolez G; Moreau C; Lopes R; Ryckewaert G; Carrière N; Auger F; Laloux C; Petrault M; Devedjian JC; Bordet R; Defebvre L; Jissendi P; Delmaire C; Devos D
    PLoS One; 2016; 11(4):e0147947. PubMed ID: 27035571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease.
    Isaias IU; Trujillo P; Summers P; Marotta G; Mainardi L; Pezzoli G; Zecca L; Costa A
    Front Aging Neurosci; 2016; 8():196. PubMed ID: 27597825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automated volumetric determination of high R
    Tessema AW; Lee H; Gong Y; Cho H; Adem HM; Lyu I; Lee JH; Cho H
    NMR Biomed; 2022 Nov; 35(11):e4795. PubMed ID: 35775868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment.
    Kan H; Uchida Y; Ueki Y; Arai N; Tsubokura S; Kunitomo H; Kasai H; Aoyama K; Matsukawa N; Shibamoto Y
    Neuroimage Clin; 2022; 33():102938. PubMed ID: 34998126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.
    Graham JM; Paley MN; Grünewald RA; Hoggard N; Griffiths PD
    Brain; 2000 Dec; 123 Pt 12():2423-31. PubMed ID: 11099445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective.
    Jara H; Sakai O; Mankal P; Irving RP; Norbash AM
    Top Magn Reson Imaging; 2006 Feb; 17(1):19-30. PubMed ID: 17179894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synchrotron XRF imaging of Alzheimer's disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration.
    Finnegan ME; Visanji NP; Romero-Canelon I; House E; Rajan S; Mosselmans JFW; Hazrati LN; Dobson J; Collingwood JF
    J Neurosci Methods; 2019 May; 319():28-39. PubMed ID: 30851339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
    Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
    Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative assessment of iron deposition in Parkinson's disease using enhanced T2 star-weighted angiography.
    Ji S; Zhang S; Mao Z; Han H; Yang Q; Zhu W; Zhu S; Xue Z
    Neurol India; 2016; 64(3):428-35. PubMed ID: 27147149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
    Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
    Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary observations of transverse relaxation rates obtained at 3 tesla from the substantia nigra of adult normal human brain.
    Helpern JA; Ordidge RJ; Gorell JM; Deniau JC; Welch KM
    NMR Biomed; 1995 Feb; 8(1):25-7. PubMed ID: 7547180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T2 relaxation time in patients with Parkinson's disease.
    Antonini A; Leenders KL; Meier D; Oertel WH; Boesiger P; Anliker M
    Neurology; 1993 Apr; 43(4):697-700. PubMed ID: 8469325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping].
    Guan JJ; Feng YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):305-311. PubMed ID: 29643036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.
    Tinaz S; Chow C; Kuo PH; Krupinski EA; Blumenfeld H; Louis ED; Zubal G
    Clin Nucl Med; 2018 Jan; 43(1):e1-e7. PubMed ID: 29112012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.